Prior studies found heterogeneity in levels at which ROR1 was expressed on CLL cells, and that ~5% of patients had CLL cells with low-to-negligible levels of ROR1 [36]. The gene discussed is ROR1; the disease is B-cell chronic lymphocytic leukemia.